Amended Safety Assessment of Methylisothiazolinone and Methylchloroisothiazolinone as Used in Cosmetics Status: Draft Report for Panel Review Release Date: May 10, 2019 Panel Meeting Date: June 6-7, 2019 The 2019 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A. Hill, Ph.D. James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Executive Director is Bart Heldreth, Ph.D. This safety assessment was prepared by Christina L. Burnett, Senior Scientific Analyst/Writer. © Cosmetic Ingredient Review 1620 L St NW, Suite 1200 ◊ Washington, DC 20036-4702 ◊ ph 202.331.0651 ◊fax 202.331.0088 ◊
[email protected] Distributed for Comment Only -- Do Not Cite or Quote Commitment & Credibility since 1976 Memorandum To: CIR Expert Panel Members and Liaisons From: Christina L. Burnett, Senior Scientific Writer/Analyst Date: May 10, 2019 Subject: Draft Amended Report on the Safety Assessment on Methylisothiazolinone and Methylchloroisothiazolinone Enclosed is the draft amended report of the safety assessment of Methylisothiazolinone and Methylchloroisothiazolinone (MCI/MI) as used in cosmetics. (It is identified as mcimi062019rep in the pdf document.) This ingredient combination functions as a preservative in cosmetics. In 1992, the final report on MCI/MI was published with the conclusion that this mixture may be safely used in rinse-off products at a concentration not to exceed 15 ppm and in leave-on cosmetic products at a concentration not to exceed 7.5 ppm.